CompletedNot Applicable

Melatonin and Hyaluronic Acid in Maxillary Sinus Augmentation

Egypt16 participantsStarted 2019-12-03

Plain-language summary

melatonin proved an ability to repair bone defects and enhance osseointegration of dental implants. Also, hyaluronic acid has osteopromoting properties. the effect of melatonin and hyaluronic acid on the newly formed bone in maxillary sinus augmentation was evaluated

Who can participate

Age range30 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age range will be between (30 - 50) years old. * Patients with missed one or more of posterior teeth with minimum residual bone height 5 mm * Adequate inter-occlusal space of at least 8 mm Exclusion Criteria: * Maxillary sinus diseases. * Previous sinus surgery like the Caldwell-Luc operation. * History of chemotherapy or radiotherapy to maxilla. * Presence of Underwood's septa/severe sinus floor convolutions. * Systemic disease affecting bone metabolism. * Uncontrolled diabetes mellitus. * Heavy smokers. * Para functional habits.

What they're measuring

change Implant stability

Timeframe: at baseline and 6 months

change in bone density

Timeframe: at baseline, 1 month and 6 months

change in vertical bone height

Timeframe: at baseline, 1 month and 6 months

change in marginal bone level

Timeframe: at baseline, 1 month and 6 months

Trial details

NCT IDNCT04625179

SponsorHams Hamed Abdelrahman

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-07

View on ClinicalTrials.gov More Edentulous; Alveolar Process, Atrophy trials